NYSE:EXAM (EXAM) (EXAM) Stock Price, News & Analysis → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free EXAM Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$35.05▼$35.1750-Day Range N/A52-Week Range$21.98▼$37.26Volume3.56 million shsAverage Volume660,679 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get (EXAM) alerts: Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About (EXAM) Stock (NYSE:EXAM)ExamWorks Group, Inc. is a provider of independent medical examinations (IMEs), peer reviews, bill reviews, Medicare compliance, case management and other related services (IME services or the IME industry). The Company conducts its business through four geographic segments, namely, the United States, Canada, the United Kingdom and Australia. The Company provides IME services through its medical panel of credentialed physicians and other medical providers. Its clients include property and casualty insurance carriers, law firms, third-party claim administrators and government agencies that use independent services to confirm the veracity of claims by sick or injured individuals and to facilitate care for workers' compensation, automotive, personal injury liability and disability insurance coverage. The Company also provides a range of services, including Medicare compliance services, bill review services and case management services.Read More Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> EXAM Stock News HeadlinesApril 28, 2024 | msn.comDaniel Suárez announces he is taking U.S. citizenship exam, shows off his constitutional knowledgeApril 28, 2024 | msn.comAccounting watchdog quizzes Big Four on AI exam cheatingApril 28, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.April 28, 2024 | msn.comTS Inter supplementary exam date 2024 check Time Table Form Date Eligibility registration fee and other detailsApril 27, 2024 | msn.comMPBSE Helpline Flooded with Queries Post Exam Results, Students Seek Guidance on Retotalling and Career OptionsApril 27, 2024 | sports.yahoo.comThe Make-up Exam: Musketeers collect walk-off winsApril 27, 2024 | msn.comWBJEE 2024: Appearing for exam tomorrow? Here are the important instructions you need to remember!April 27, 2024 | msn.comUP: Profs passing students who wrote Jai Shri Ram and cricketers' names in exam answer sheets suspendedApril 28, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.April 26, 2024 | yahoo.comKaiju No. 8 Episode 3 Trailer: How Will Kafka Perform on the Defense Force Exam?April 26, 2024 | msn.comMP Board Exam Result: Class 12 Result Malpha School's Zero Result Sparks Villagers' Fury In KhetiaApril 26, 2024 | msn.comTeacher faked own exam results to land science master job at high schoolApril 26, 2024 | msn.com6,680 pass April 2024 Civil Engineering board examApril 26, 2024 | msn.comState Superintendent says options available for students that fail ACAP examApril 26, 2024 | thetimes.co.ukWant to get into Venice? Take my exam firstApril 26, 2024 | msn.comRRB Opens Window For Exam Fee Refund: Here's Link to Update Bank DetailsApril 26, 2024 | msn.comJEE Main exam results 2024: Six out of top ten rankers are students of Narayana GroupApril 26, 2024 | yahoo.comBizzy Smith Discovered Breast Cancer After ‘The Amazing Race’ Exam: ‘Saved My Life’April 25, 2024 | msn.com4 graduates from Cebu universities top civil engineer board examApril 25, 2024 | msn.comWho got into Boston’s exam schools this fall? BPS offers an initial glimpse at the dataApril 25, 2024 | msn.comMP Board Exam Results: Troubling Trend In Khetia Village, Malpha School Hits With Zero Pass RateApril 25, 2024 | msn.com'He barely uses his phone': Dubai student who topped JEE exam shares secret to 100% markApril 25, 2024 | msn.comImpact of COVID-19 'will affect exam results well into the 2030s,' says studyApril 25, 2024 | msn.comKarnataka 2nd PUC Exam 2 Hall Ticket Released On kseab.karnataka.gov.in, Know How To DownloadApril 25, 2024 | msn.comKarnataka: Dates for the second PUC Exam-2 are out. Details here.April 25, 2024 | msn.comTS Inter Results 2024: Re-counting, Re-evaluation, Supplementary exam registration from today on tsbie.cgg.gov.inApril 25, 2024 | msn.comKarnataka II PUC Exam 2 admit card out, direct link and steps to downloadSee More Headlines Receive EXAM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (EXAM) and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/10/2016Today4/28/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorN/A Industry N/A Sub-IndustryHealth Care Services Current SymbolNYSE:EXAM CUSIP30066A10 CIK1498021 Webwww.examworks.com Phone+1-404-9522400FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report EXAM Stock Analysis - Frequently Asked Questions How were (EXAM)'s earnings last quarter? (EXAM) (NYSE:EXAM) released its quarterly earnings data on Tuesday, May, 10th. The business services provider reported $0.08 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.08. The business services provider had revenue of $226.50 million for the quarter, compared to analyst estimates of $217.47 million. (EXAM)'s revenue for the quarter was up 15.4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.05 earnings per share. What other stocks do shareholders of (EXAM) own? Based on aggregate information from My MarketBeat watchlists, some companies that other (EXAM) investors own include Ciena (CIEN), Community Health Systems (CYH), Halozyme Therapeutics (HALO), Ionis Pharmaceuticals (IONS), Nektar Therapeutics (NKTR), Precigen (PGEN), Alnylam Pharmaceuticals (ALNY), Ambarella (AMBA), Arctos NorthStar Acquisition (ANAC) and Best Buy (BBY). This page (NYSE:EXAM) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHis win rate puts Warren Buffett to shame… Investing DailyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyUrgent Nvidia WarningAltimetryBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (EXAM) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
